Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Enavogliflozin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Daewoong Pharmaceutical Unveils Innovative Drug Delivery Tech
    Daewoong Pharmaceutical Unveils Innovative Drug Delivery Tech

    09 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/daewoong-pharmaceutical-unveils-innovative-drug-delivery-technologies-in-milanfrom-worlds-first-microneedle-therapy-to-once-a-month-obesity-treatment-302272175.html

    PR NEWSWIRE
    09 Oct 2024
    Share Share
    Daewoong Presents Enavogliflozin's Phase 3 Results At ADA Conference
    Daewoong Presents Enavogliflozin's Phase 3 Results At ADA Conference

    19 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/daewoong-presents-enavogliflozins-phase-3-pooled-analysis-results-at-84th-ada-conference-302176658.html

    PR NEWSWIRE
    19 Jun 2024
    Share Share
    M8 and Daewoong strengthen their partnership by signing agreement for Envlo
    M8 and Daewoong strengthen their partnership by signing agreement for Envlo

    28 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/m8-pharmaceuticals-and-daewoong-pharmaceutical-strengthen-their-strategic-partnership-by-signing-an-exclusive-licensing-agreement-for-envlo-enavoglifozin-for-brazil-and-mexico-301755865.html

    PR NEWSWIRE
    28 Feb 2023
    Share Share
    Daewoong Announces Successful Phase 3 Topline Results for Enavogliflozin TCT
    Daewoong Announces Successful Phase 3 Topline Results for Enavogliflozin TCT

    25 Feb 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/daewoong-pharmaceutical-announces-successful-phase-3-topline-results-for-new-antidiabetic-drugs-triple-combination-therapy-301490372.html

    PRNEWSWIRE
    25 Feb 2022
    Share Share